Back to Search
Start Over
Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells.
- Source :
-
Anatomical record (Hoboken, N.J. : 2007) [Anat Rec (Hoboken)] 2015 Feb; Vol. 298 (2), pp. 386-95. Date of Electronic Publication: 2014 Jul 17. - Publication Year :
- 2015
-
Abstract
- Previous studies have suggested that the novel BH3 mimetic S1 could induce apoptosis in diverse tumor cell lines through endoplasmic reticulum (ER) stress or mitochondrial cell death pathways. The activation of c-Jun N-terminal kinase (JNK) through inositol requiring enzyme-1 (IRE1) is closely connected to ER stress-induced apoptosis. However, the role of JNK is complex, as there are different JNK subtypes and the function of each subtype is still not entirely clear. Here we found that the mRNA expression of JNK3 was continuously high in S1-treated human ovarian cancer SKOV3/DDP cells using a human unfolded protein response (UPR) pathway PCR array. Pharmacological inhibition of JNK3 increased cell sensitivity to apoptosis induced by S1. Furthermore, inhibition of JNK3 induced accumulation of both acidic compartment and p62, and upregulated ROS production. Our results suggest that JNK3 plays a pro-survival role during ER stress through preventing the block of autophagic flux and reducing oxidative stress in SKOV3/DDP cells. Inhibition of JNK3 may be a potential method to enhance the killing effect of the Bcl-2 inhibitor S1.<br /> (© 2014 Wiley Periodicals, Inc.)
- Subjects :
- Antineoplastic Agents pharmacology
Antineoplastic Agents therapeutic use
Apoptosis physiology
BH3 Interacting Domain Death Agonist Protein biosynthesis
Biomimetic Materials pharmacology
Biomimetic Materials therapeutic use
Cell Line, Tumor
Drug Combinations
Drug Resistance, Neoplasm physiology
Female
Humans
Mitogen-Activated Protein Kinase 10 biosynthesis
Molecular Mimicry physiology
Ovarian Neoplasms drug therapy
Oxonic Acid pharmacology
Oxonic Acid therapeutic use
Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors
Proto-Oncogene Proteins c-bcl-2 biosynthesis
Tegafur pharmacology
Tegafur therapeutic use
Apoptosis drug effects
BH3 Interacting Domain Death Agonist Protein antagonists & inhibitors
Drug Resistance, Neoplasm drug effects
Mitogen-Activated Protein Kinase 10 antagonists & inhibitors
Molecular Mimicry drug effects
Ovarian Neoplasms enzymology
Subjects
Details
- Language :
- English
- ISSN :
- 1932-8494
- Volume :
- 298
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Anatomical record (Hoboken, N.J. : 2007)
- Publication Type :
- Academic Journal
- Accession number :
- 25044439
- Full Text :
- https://doi.org/10.1002/ar.22991